Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 3Dermatologic 3Gynecologic 2Genitourinary 2Gastrointestinal 2Thoracic 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1CNS 1

Conditions

Neuroblastoma 18Gliosarcoma 7Glioblastoma 7Brain Neoplasms 7Glioma 5Central Nervous System Neoplasms 5Astrocytoma 5Sarcoma 3Oligodendroglioma 3Neoplasm Metastasis 3Meningioma 3Melanoma 3Carcinoma, Non-Small-Cell Lung 3Testicular Neoplasms 2Testicular Germ Cell Tumor 2Ovarian Neoplasms 2Neuroectodermal Tumors, Primitive 2Lymphoma 2Liver Neoplasms 2Ependymoma 2Breast Neoplasms 2Wilms Tumor 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Teratoma, Testicular 1Teratoma 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1

Interventions

Temozolomide 19Bevacizumab 14Irinotecan 12Carboplatin 10Cyclophosphamide 9Radiosurgery 8Lomustine 8Radiotherapy 7pembrolizumab 6Vincristine 6Topotecan 6Drug Therapy 6Surgical Procedures, Operative 5Etoposide 5Doxorubicin 5Cisplatin 53-Iodobenzylguanidine 5trametinib 4Metformin 4Gemcitabine 4Dexamethasone 4Blood Specimen Collection 4poly ICLC 3dabrafenib 3Vorinostat 3Trastuzumab 3Therapeutics 3Radiation 3Paclitaxel 3Observation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × aldesleukin × CNS × Clear all
NCT01404702 2014-12-02

Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma

University of Alabama at Birmingham

Phase 1 Terminated
4 enrolled
CNS

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡